A double-blind randomized, placebo controlled study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of intravenous ganaxolone as adjunctive therapy to treat subjects with status epilepticus

September 24, 2018
https://clinicaltrials.gov/ct2/show/NCT03350035
Epilepsy
Principal Investigator: Panayiotis N Varelas, MD
status, epilepticus
Accepting Participants
(313)916-3346